Purpose of this Study
We are doing this study to find out how different imaging techniques can help with the evaluation of glioblastoma.
Who Can Participate?
Eligibility
Adults ages 18+ who:
<ul>
<li>Have newly diagnosed glioblastoma (IDH wild type)</li>
<li>Are planning to receive standard-of-care treatment</li>
<li>Will have diagnostic surgery within 7 weeks before joining the study</li>
<li>Are not allergic to imaging agents</li></ul>
For more information about this study, please call 919-684-5301.
<ul>
<li>Have newly diagnosed glioblastoma (IDH wild type)</li>
<li>Are planning to receive standard-of-care treatment</li>
<li>Will have diagnostic surgery within 7 weeks before joining the study</li>
<li>Are not allergic to imaging agents</li></ul>
For more information about this study, please call 919-684-5301.
Age Range
18-110
Sex/Genders
Male (cisgender)
Female (cisgender)
Looking for Healthy Participants
No
What is Involved?
If you chose to join, you will have at least two study MRI scans.
Locations
Duke University Hospital
Visit Timing
Weekdays
Compensation
No
Spanish Materials Available
Yes
Study Details
Full Title
EAF223: Phase II Glioblastoma Accelerated Biomarkers Learning Environment Trial (GABLE)
Principal Investigator
Annick
Desjardins
Protocol Number
PRO00115772
NCT ID
NCT06319027
Phase
II
Enrollment Status
Pending Open to Enrollment